Section
E09.1
Drug or chemical induced diabetes mellitus with ketoacidosis
Hierarchy
Notes
- All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Code First
-
poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4)
Use Additional
-
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
-
code to identify control using:
-
injectable non-insulin antidiabetic drugs (Z79.85)
- Z79.85 Long-term (current) use of injectable non-insulin antidiabetic drugs
-
insulin (Z79.4)
- Z79.4 Long term (current) use of insulin
-
oral antidiabetic drugs (Z79.84)
- Z79.84 Long term (current) use of oral hypoglycemic drugs
-
oral hypoglycemic drugs (Z79.84)
- Z79.84 Long term (current) use of oral hypoglycemic drugs
Excludes 1
- E08 Diabetes mellitus due to underlying condition
-
gestational diabetes (O24.4-)
- O24.4 Gestational diabetes mellitus
- P70.2 Neonatal diabetes mellitus
-
postpancreatectomy diabetes mellitus (E13.-)
- E13 Other specified diabetes mellitus
-
postprocedural diabetes mellitus (E13.-)
- E13 Other specified diabetes mellitus
-
secondary diabetes mellitus NEC (E13.-)
- E13 Other specified diabetes mellitus
- E10 Type 1 diabetes mellitus
- E11 Type 2 diabetes mellitus
- P70-P74 Transitory endocrine and metabolic disorders specific to newborn (P70-P74)